Showing all 3 results
L- ornithine-L-aspartate tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical and physical stability of the highly hygroscopic amino acid salt.
Active Ingredient Strength Primary Clinical Function L-Ornithine L-Aspartate (LOLA) 150 mg / 250 mg Hepatology Maintenance Standard: Base therapeutic units for long-term chronic management of severe Non-Alcoholic Fatty Liver Disease (NAFLD), alcoholic hepatitis, and mild hyperammonemia. L-Ornithine L-Aspartate (LOLA) 500 mg Acute Detoxification Standard: High-efficacy adult therapy utilized for immediate ammonia reduction and the step-down management of Hepatic Encephalopathy following hospital discharge. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Moisture-Barrier Film Diluent / Superdisintegrant / Glidant / Film-Coating (Engineered specifically to lock out atmospheric moisture, preventing the heavy 500mg amino acid tablet from swelling, cracking, or prematurely degrading before it reaches the patient’s stomach) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, high-volume chronic hepatology dispensing regimens).
PANCREATIN + ORNITHINE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the biological proteins and the highly hygroscopic amino acid.
Active Ingredient Strength Primary Clinical Function Pancreatin (Porcine Origin) Ph.Eur./USP 170 mg
(Standardized Lipase/Protease/Amylase)Gastrointestinal Standard: Intraluminal enzymatic digestion of complex macronutrients to reverse malabsorption. L-Ornithine (as L-Ornithine L-Aspartate / LOLA) 150 mg Hepatology Standard: Hepatic urea cycle activation for aggressive ammonia detoxification and liver regeneration. Excipients Methacrylic Acid Copolymer / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate Enteric Barrier Coating (for Pancreatin) / Diluent / Superdisintegrant (Engineered specifically to separate the amino acid from the enzymes and ensure targeted duodenal release of the biologicals) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance chronic hepato-gastro dispensing regimens).
Rifaximin Ph.Eur Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the crystalline polymorph structure.
Active Ingredient Strength Primary Clinical Function Rifaximin Ph.Eur. 200 mg / 400 mg GI Infection Dose: Acute eradication of non-invasive E. coli (Traveler’s Diarrhea). Rifaximin Ph.Eur. 550 mg Hepatology & IBS Standard: High-dose maintenance therapy for Hepatic Encephalopathy and IBS-D. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Propylene Glycol Diluent / Superdisintegrant / Glidant / Film-Coating Plasticizer (Engineered for optimal dispersion throughout the intestinal lumen) *Pack Sizes: 10×10 Alu-Alu Blisters or 14-Tablet Blisters (Optimized specifically for standard acute infection or chronic hepatology dispensing regimens).
